Stroke Care in OECD Countries: A Comparison of Treatment, Costs and Outcomes in 17 Countries

DISCLAIMER: All opinions in this column reflect the views of the author(s), not of EURACTIV Media network.

Stroke is an ageing-related common disease, whose treatment entails high cost and leaves older populations with considerable health implications. This study provides information on the treatment, costs and health outcomes of stroke in a number of European countries.

This study examines treatment trends and health outcomes for stroke in 17 OECD member countries. The reference countries show variations in the prevention of stroke, the hospitalisation of stroke patients, and in the frequency of use of diagnostic tests. The health outcomes greatly differ among countries, with some countries having higher case fatality rates than others. Finally, some countries were found to spend more on stroke care.

The study concludes that there is apparent benefit from a broad-based approach to managing stroke that includes prevention, acute care and rehabilitation. In addition, there seems to be specific potential benefit from the use of stroke units that may not be fully realised in most of the reference countries in this study.

To read the full OECD report, click


Subscribe to our newsletters